You are viewing a free limited preview of Aileron Therapeutics, Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Aileron Therapeutics, Inc. is a privately-held, venture capital backed biopharmaceutical company and was formerly known as Renegade Therapeutics, Inc. Aileron Therapeutics specializes in developing biologics for the treatment of cancer. Renegade Therapeutics, Inc. changed its name to Aileron Therapeutics, Inc. in 2007. Founded in 2001, Aileron Therapeutics is headquartered in Cambridge, Massachusetts.
| Company Tags: | VC Backed |
| Year Founded: | 2001 |
| Fiscal Year End: | 12/31 |
| City: | Cambridge |
| State/Province: | Massachusetts |
| Country: | United States |
| Phone: | View |
| Website: | www.aileronrx.com |
| Technology > Biotechnology > Biopharmaceuticals |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Jun. 2007 | View | C-1 | Venture Capital | |
| Jun. 2007 | View | C-1 | Venture Capital | |
| Details | Total Round C-1 View | |||
| Nov. 2007 | View | C-2 | Venture Capital | |
| Nov. 2007 | View | C-2 | Venture Capital | |
| Details | Total Round C-2 View | |||
| Apr. 2008 | View | C-3 | Venture Capital | |
| Apr. 2008 | View | C-3 | Venture Capital | |
| Apr. 2008 | View | C-3 | Non-Profit | |
| Apr. 2008 | View | C-3 | Other Investment Firm | |
| Details | Total Round C-3 View | |||
| Jun. 2009 | View | D-1 | Venture Capital | |
| Jun. 2009 | View | D-1 | Corporate | |
| Jun. 2009 | View | D-1 | Venture Capital | |
| Jun. 2009 | View | D-1 | Venture Capital | |
| Jun. 2009 | View | D-1 | Venture Capital | |
| Jun. 2009 | View | D-1 | Venture Capital | |
| Jun. 2009 | View | D-1 | Venture Capital | |
| Details | Total Round D-1 View | |||
| Jan. 2013 | View | D-2 | Venture Capital | |
| Jan. 2013 | View | D-2 | Venture Capital | |
| Jan. 2013 | View | D-2 | Venture Capital | |
| Jan. 2013 | View | D-2 | Venture Capital | |
| Jan. 2013 | View | D-2 | Venture Capital | |
| Jan. 2013 | View | D-2 | Venture Capital | |
| Details | Total Round D-2 View | |||
| Total of Funding Shown Above View | ||||
Missing a deal? Tell us about it! tips@privco.com
|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,401 |
| Private Investors | 12,095 |
| Private M&A Deals | 43,310 |
| VC/Funding Rounds | 36,248 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of Aileron Therapeutics, Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
EXPORT COMPANY'S DATA TO EXCEL:
Full Online Report